| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9455 |
| Human Intestinal Absorption | HIA+ | 0.9726 |
| Caco-2 Permeability | Caco2+ | 0.6509 |
| P-glycoprotein Substrate | Non-substrate | 0.8460 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9807 |
| Non-inhibitor | 0.9784 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9145 |
| Distribution |
| Subcellular localization | Lysosome | 0.5561 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8473 |
| CYP450 2D6 Substrate | Non-substrate | 0.8291 |
| CYP450 3A4 Substrate | Non-substrate | 0.8163 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8951 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8978 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9754 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9515 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9850 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8328 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9621 |
| Non-inhibitor | 0.9663 |
| AMES Toxicity | Non AMES toxic | 0.9390 |
| Carcinogens | Carcinogens | 0.6791 |
| Fish Toxicity | Low FHMT | 0.6292 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.7918 |
| Honey Bee Toxicity | High HBT | 0.7834 |
| Biodegradation | Ready biodegradable | 0.5258 |
| Acute Oral Toxicity | III | 0.5553 |
| Carcinogenicity (Three-class) | Non-required | 0.4947 |